The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Methemoglobinemia
Publications
THE RELATION OF METHEMOGLOBIN TO THE CYANOSIS OBSERVED AFTER SULFANILAMIDE ADMINISTRATION.
The Journal of clinical investigation 1940 Jan;19;83-7 — 1940 Jan — 83-7
THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.
The Journal of clinical investigation 1939 Sep;18;507-19 — 1939 Sep — 507-19
A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL.
The Journal of clinical investigation 1938 Nov;17;699-710 — 1938 Nov — 699-710
Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report.
Gynecologic oncology 2005 Jun;97;953-6 — 2005 Jun — 953-6